Garuda Therapeutics Funding & Investors
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.
garudatx.comTotal Amount Raised: $134,000,000
Garuda Therapeutics Funding Rounds
Series B
$62,000,000
Series B Investors
Aisling CapitalCormorant Asset ManagementNorthpond VenturesOrbiMedMass General Brigham VenturesSectoral Asset ManagementAlexandria Venture InvestmentsSeries A
$72,000,000
Series A Investors
Aisling CapitalNorthpond VenturesOrbiMedCormorant Asset ManagementMonashee Investment ManagementSectoral Asset ManagementRidgeback CapitalMass General Brigham VenturesResilience
Funding info provided by Diffbot.